Neurotensin‐Conjugated Reduced Graphene Oxide with Multi‐Stage Near‐Infrared‐Triggered Synergic Targeted Neuron Gene Transfection In Vitro and In Vivo for Neurodegenerative Disease Therapy
- 2 November 2016
- journal article
- research article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 5 (23) , 3016-3026
Abstract
Delivery efficiency with gene transfection is a pivotal point in achieving maximized therapeutic efficacy and has been an important challenge with central nervous system (CNS) diseases. In this study, neurotensin (NT, a neuro‐specific peptide)‐conjugated polyethylenimine (PEI)‐modified reduced graphene oxide (rGO) nanoparticles with precisely controlled two‐stage near‐infrared (NIR)‐laser photothermal treatment to enhance the ability to target neurons and achieve high gene transfection in neurons. First‐stage NIR laser irradiation on the cells with nanoparticles attached on the surface can increase the permeability of the cell membrane, resulting in an apparent increase in cellular uptake compared to untreated cells. In addition, second‐stage NIR laser irradiation on the cells with nanoparticles inside can further induce endo/lysosomal cavitation, which not only helps nanoparticles escape from endo/lysosomes but also prevents plasmid DNA (pDNA) from being digested by DNase I. At least double pDNA amount can be released from rGO‐PEI‐NT/pDNA under NIR laser trigger release compared to natural release. Moreover, in vitro differentiated PC‐12 cell and in vivo mice (C57BL/6) brain transfection experiments have demonstrated the highest transfection efficiency occurring when NT modification is combined with external multi‐stage stimuli‐responsive NIR laser treatment. The combination of neuro‐specific targeting peptide and external NIR‐laser‐triggered aid provides a nanoplatform for gene therapy in CNS diseases.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (102-2221-E-009-024-MY3)
This publication has 30 references indexed in Scilit:
- Gene therapy clinical trials worldwide to 2012 – an updateThe Journal of Gene Medicine, 2013
- Polyethylene Glycol and Polyethylenimine Dual‐Functionalized Nano‐Graphene Oxide for Photothermally Enhanced Gene DeliverySmall, 2013
- Effective Non-Viral Delivery of siRNA to Acute Myeloid Leukemia Cells with Lipid-Substituted PolyethyleniminesPLOS ONE, 2012
- Functional Graphene Oxide as a Nanocarrier for Controlled Loading and Targeted Delivery of Mixed Anticancer DrugsSmall, 2010
- Dopamine Gene Therapy for Parkinson’s Disease in a Nonhuman Primate Without Associated DyskinesiaScience Translational Medicine, 2009
- Tumor specific ultrasound enhanced gene transfer in vivo with novel liposomal bubblesJournal of Controlled Release, 2008
- Nonviral Approaches for Neuronal Delivery of Nucleic AcidsPharmaceutical Research, 2007
- Neuron‐specific delivery of nucleic acids mediated by Tet1‐modified poly(ethylenimine)The Journal of Gene Medicine, 2007
- Enhanced transfection of tumor cellsin vivousing “Smart” pH-sensitive TAT-modified pegylated liposomesJournal of Drug Targeting, 2007
- Drug delivery to damaged brainBrain Research Reviews, 2001